Gary M. Myles, Ph.D.

prometheus patents patent federal circuit supreme court biotechnology myriad 35 usc 101 classen bilski dna diagnostic methods mayo personalized medicine nucleic acids intellectual property invention 35 usc 112 enablement written description commil v. cisco 35 usc 271 induced infringement scotus patent eligibility patent law bio amicus brief commil v. cisco corporate limited liability companys llc corporations corporate entity startup university of north carolina aziz sancar department of biochemistry nobel prize in chemistry nobel prize school of medicine 103 novely first to invent 102 written description first inventor to file 112 first to file america invents act prior art enablement aia law non-obviousness biochemistry education biophysics law school publications legal experience life sciences board memberships resume science gary myles scientific experience ph.d. honors curriculum vitae incentive to innovate cdna eligibility antibody genomic protein gene chakrabarty law of nature product of nature in re kubin patent office amgen v. chugai association of molecular pathology myriad genetics proteins antibodies claims genes laws of nature cdnas products of nature commercial objectives cost-effective deals value-added start-up financing due diligence product focus